04.05.2005 22:33:00
|
Millipore CFO at Baird's 2005 Growth Stock Conference on May 10th, 20
Business Editors/Medical Editors
Baird's 2005 Growth Stock Conference
BILLERICA, Mass.--(BUSINESS WIRE)--May 4, 2005--Millipore Corporation (NYSE:MIL) announced today that Kathy Allen, Millipore's Chief Financial Officer will be speaking at Baird's 2005 Growth Stock Conference on May 10th at 2:05 Eastern Time. The conference is being held at the Four Seasons Hotel in Chicago, IL. Ms. Allen's presentation will be webcast and available for viewing live and after the conference. You can access the webcast from the Millipore home page, www.millipore.com. You can also access the webcast at this web site: http://www.wsw.com/webcast/rwbaird11/mil/.
About Millipore
Millipore is a multinational bioscience company that provides technologies, tools and services for the discovery, development and production of new therapeutic drugs. It serves the life science research, biotechnology and pharmaceutical industries. For more information about Millipore visit www.millipore.com.
--30--JO/bo*
CONTACT: Millipore Corporation Investor Contact Geoffrey Helliwell, 978-715-1041 or 800-225-3384 Geoffrey_Helliwell@Millipore.com or Media Contact Thomas Anderson, 978-715-1043 or 800-225-3384 Thomas_Anderson@Millipore.com
KEYWORD: MASSACHUSETTS ILLINOIS TRACK INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL DEVICES BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: Millipore Corporation
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck KGaAmehr Nachrichten
05.02.25 |
Schwacher Wochentag in Frankfurt: LUS-DAX fällt zum Start (finanzen.at) | |
05.02.25 |
Handel in Frankfurt: DAX präsentiert sich zum Handelsstart leichter (finanzen.at) | |
04.02.25 |
LUS-DAX aktuell: LUS-DAX legt zum Ende des Dienstagshandels den Rückwärtsgang ein (finanzen.at) | |
04.02.25 |
Zuversicht in Frankfurt: DAX beendet die Sitzung weit in der Gewinnzone (finanzen.at) | |
04.02.25 |
Schwacher Handel: LUS-DAX am Nachmittag in der Verlustzone (finanzen.at) | |
04.02.25 |
Optimismus in Frankfurt: DAX in Grün (finanzen.at) | |
04.02.25 |
Merck shares sink 11% after vaccine shipments to China halted (Financial Times) | |
04.02.25 |
Gute Stimmung in Frankfurt: DAX präsentiert sich fester (finanzen.at) |
Analysen zu Merck KGaAmehr Analysen
07.02.25 | Merck Overweight | JP Morgan Chase & Co. | |
31.01.25 | Merck Buy | Deutsche Bank AG | |
20.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
17.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
09.01.25 | Merck Buy | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
Merck KGaA | 139,90 | -1,44% |
Indizes in diesem Artikel
S&P 500 | 6 025,99 | -0,95% |